Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
oral selective estrogen receptor modulator .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word toremifene.
Examples
-
Experts with the European Medicines Agency noted that the benefits of the drug, generically known as toremifene, were greater than the risks but said it should be restricted, according to Reuters.
Memphis Business News - Local Memphis News | Memphis Business Journal 2009
-
Acapodene consists of an 80-mg dose of a drug known as toremifene, used by doctors for years
unknown title 2009
-
Orion originally developed toremifene for treatment of breast cancer.
-
In May the US pharmaceutical company GTx announced that it had ended studies on the use of 80 mg doses of toremifene for treating the adverse effects of prostate cancer treatment.
-
GTx (Nasdaq: GTXI) received a $1.7 million non-cash impairment charge in the second quarter due to an unsuccessful conclusion of the phase III clinical trial of toremifene 20 mg for the prevention of prostate cancer.
Jacksonville Business News - Local Jacksonville News | Jacksonville Business Journal 2010
-
In addition, this estimate does not include any costs related to any additional clinical development of our SARM program, nor does it include any additional costs that we may be required to bear to continue the development of toremifene 80 mg if the funding from Ipsen is not sufficient to pay all clinical trial costs of a second pivotal Phase III clinical trial of toremifene 80 mg.
GuruFocus Updates - 2010
-
GTx (Nasdaq: GTXI) received a $1.7 million non-cash impairment charge in the second quarter due to an unsuccessful conclusion of the phase III clinical trial of toremifene 20 mg for the prevention of prostate cancer.
National Business News - Local Business News | bizjournals 2010
-
We have estimated the performance obligation period to be ten years for the development of toremifene under our collaboration agreement with Ipsen which is based upon the estimated development period for toremifene 80 mg.
GuruFocus Updates - 2010
-
GTx (Nasdaq: GTXI) received a $1.7 million non-cash impairment charge in the second quarter due to an unsuccessful conclusion of the phase III clinical trial of toremifene 20 mg for the prevention of prostate cancer.
Boston Business News - Local Boston News | Boston Business Journal 2010
-
GTx (Nasdaq: GTXI) received a $1.7 million non-cash impairment charge in the second quarter due to an unsuccessful conclusion of the phase III clinical trial of toremifene 20 mg for the prevention of prostate cancer.
Philadelphia Business News - Local Philadelphia News | The Philadelphia Business Journal 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.